Skip to main contentAI and Advanced
/
MEDICO · NSEMarket ticker unavailable · configure an authorised index feed
ME
NSE · Equity shares · Biotechnology & Drugs-0.39 · -1.09%
Medico Remedies MEDICO
NSE:INR 35.35
BSE:INR 38.21
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for MEDICO
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 35.74
Day rangeINR 35.11 — INR 36.98
52-week rangeINR 30.22 — INR 56.88
Volume1.40 L
Market cap315.42
P/E20.6
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)206.38
Net Income (INR Cr)13.12
Rev Growth (5 Year %)11.02
EPS Growth (5 Year %)4.81
P/E Ratio20.6
Book Value9.09
EPS1.58
Price/BV3.89Computed
Research path: Interpret Medico Remedies's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
MEDICOMedico Remedies1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 153.4 | 119.8 | 96.2 |
| Cash Equivalents | 1.91 | 0.95 | 0.18 |
| Other Liabilities Total | 0 | 0 | 0 |
| Long Term Debt | 0.29 | 0 | 0.87 |
| Common Stock Total | 58.88 | 45.87 | 35.77 |
| Other Current Assets Total | 12.87 | 10.03 | 6.05 |
| Total Assets | 153.4 | 119.8 | 96.2 |
| Current Portof LT Debt/Capital Leases | 0.37 | 0.5 | 0.43 |
| Total Equity | 75.47 | 62.47 | 52.37 |
| Long Term Investments | 0.88 | 1.05 | 0.76 |
| Retained Earnings(Accumulated Deficit) | 16.6 | 16.6 | 16.6 |
| Total Common Shares Outstanding | 8.3 | 8.3 | 8.3 |
| Tangible Book Valueper Share Common Eq | 9.09 | 7.52 | 6.3 |
| Total Liabilities | 77.93 | 57.33 | 43.82 |
| Total Debt | 19.2 | 14.7 | 8.05 |
| Short Term Investments | 1.85 | 1.45 | 0 |
| Cashand Short Term Investments | 3.76 | 2.55 | 1.55 |
| Total Receivables Net | 82.27 | 57.37 | 49.83 |
| Notes Payable/Short Term Debt | 18.55 | 13.83 | 6.75 |
| Accounts Receivable-Trade Net | 81.99 | 57.18 | 49.63 |
| Property/Plant/Equipment Total-Net | 22.95 | 21.58 | 21.37 |
| Total Current Liabilities | 77.64 | 56.96 | 42.81 |
| Total Inventory | 30.02 | 26.73 | 16.34 |
| Accounts Payable | 49.33 | 34.71 | 31.51 |
| Other Currentliabilities Total | 9.4 | 7.92 | 4.12 |
| Total Long Term Debt | 0.29 | 0.37 | 0.87 |
| Intangibles Net | 0.04 | 0.07 | 0.12 |
| Other Long Term Assets Total | 0.62 | 0.42 | 0.18 |
| Total Current Assets | 128.92 | 96.68 | 73.76 |
| Capital Lease Obligations | 0 | 0.37 | Not available |
| Accumulated Depreciation Total | Not available | -22.73 | Not available |
| Cash | Not available | 0.14 | 1.36 |
| Property/Plant/Equipment Total-Gross | Not available | 43.95 | Not available |
| Deferred Income Tax | Not available | 0 | 0.14 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio1.11
Price to Sale Ratio1.53
Growth
Debt 5Yr CAGR %8.01
Margins
Operating Margin 12m6.75
Operating Margin 5y Avg6.28
Net Profit Margin 12m6.36
Net Profit Margin 5y5.71
Yield
Dividend Yield %0
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk47.99
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | INR 1,937.3 | 4.65 L | 38.4 | — |
| Divi's Laboratories | INR 7,370 | 1.96 L | 73.32 | — |
| Torrent Pharmaceuticals | INR 4,981 | 1.69 L | 72.73 | — |
| Cipla | INR 1,406.35 | 1.14 L | 27.57 | — |
| Zydus Lifesciences | INR 1,117.9 | 1.11 L | 21.19 | — |
Shareholding
Ownership
- Promoter
- 61.38%
- FII
- 0.08%
- Other
- 38.54%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Medico Remedies Ltd is Rated Sell - MarketsMojoMarket news · 19 Jul 2026, 10:00 pm
Medico Remedies Ltd is Rated Sell MarketsMojo
Enterprise value to revenue forward of Medico Remedies Ltd. – NSE:MEDICO - TradingViewMarket news · 8 Jul 2026, 12:01 am
Enterprise value to revenue forward of Medico Remedies Ltd. – NSE:MEDICO TradingView
Price to book forward of Medico Remedies Ltd. – BSE:MEDICO - TradingViewMarket news · 7 Jul 2026, 5:08 pm
Price to book forward of Medico Remedies Ltd. – BSE:MEDICO TradingView
Price to sales forward of Medico Remedies Ltd. – NSE:MEDICO - TradingViewMarket news · 5 Jul 2026, 8:13 pm
Price to sales forward of Medico Remedies Ltd. – NSE:MEDICO TradingView
Medico Remedies Ltd Upgraded to Hold on Improved Technicals and Financial Metrics - MarketsMojoMarket news · 3 Jul 2026, 8:37 am
Medico Remedies Ltd Upgraded to Hold on Improved Technicals and Financial Metrics MarketsMojo
Medico Remedies hikes credit facilities to Rs 42 crore, CRISIL reaffirms ratings - WhalesbookMarket news · 29 Jun 2026, 6:19 pm
Medico Remedies hikes credit facilities to Rs 42 crore, CRISIL reaffirms ratings Whalesbook
Corporate actions
Events
- board MeetingsAudited Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- board MeetingsQuarterly Results
- board MeetingsAudited Results
- board MeetingsQuarterly Results
Rusaka Markets Community
Discussion and sentiment for Medico Remedies
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Medico Remedies Limited is an India-based company, principally engaged in the pharmaceutical business. The Company is involved in the development, manufacture and sale of pharmaceutical and nutraceutical products. It focuses on anti-infective, Beta-Lactams, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, hematinic and other supplements. The Company also manufactures and markets capabilities in other drugs such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Pediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others. Its syrups include Medivit Syrup and Ferrovit Syrup.
Company facts
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- NSE Code
- MEDICO
- BSE Code
- 540937
Questions
Stock FAQ
What is the symbol and ISIN of Medico Remedies?
Medico Remedies has the symbol MEDICO and ISIN - INE630Y01024.
What is the current price of Medico Remedies?
Medico Remedies is currently trading at INR 35.35.
What are the year high and year low of Medico Remedies?
Medico Remedies has a year high of INR 56.88 and a year low of INR 30.22.
What is the market capitalization of Medico Remedies?
Medico Remedies has a market capitalization of INR 315.42 crore.
What is the P/E ratio of Medico Remedies?
Medico Remedies has a P/E ratio of 20.60.
What is the dividend yield of Medico Remedies?
Medico Remedies has a dividend yield of 0.00%.
How is the financial performance of Medico Remedies based on revenue, net income, and EPS?
Medico Remedies has revenue of INR 206.38 crore, net income of INR 13.12 crore, and EPS of INR 1.59.
What is the book value of Medico Remedies?
Medico Remedies has a book value of INR 9.09.
What is the debt-to-equity ratio of Medico Remedies?
Medico Remedies has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Medico Remedies?
Medico Remedies has a price-to-book ratio of 3.89 and a price-to-sales ratio of 1.53.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.